{"id":282666,"date":"2026-10-01T10:04:41","date_gmt":"2026-10-01T04:34:41","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=282666"},"modified":"2026-10-01T10:04:41","modified_gmt":"2026-10-01T04:34:41","slug":"why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/","title":{"rendered":"Alkem Laboratories Ltd. (ALKEM) 52 Week Low Streak: second straight session near yearly low"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/alkem\/alkem-laboratories-ltd-share-price-today\">Alkem Laboratories Ltd. (ALKEM)<\/a> share price is trading within 2% of its 52-week low today and stood at Rs 5,119, down 0.52% from the previous close. Market cap was Rs 62,609.02 crore.<\/em><\/div>\n<div>\n<p style=\"margin-top:0!important;\">Alkem Laboratories Ltd. 52 Week Low Streak has now extended to a second straight session, with the stock trading within 2% of its 52-week low across the streak and the cumulative move down 2.24%. The latest trough seen in the streak was Rs 5,115, while the stock was last trading at Rs 5,119. The supplied data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued weakness.<\/p>\n<p>At 9:23 AM IST, Alkem Laboratories Ltd. was trading below its previous close of Rs 5,146 after opening at Rs 5,199.35 and touching the same level as the day high before moving to Rs 5,115 at the day low. The market capitalisation stood at Rs 62,609.02 crore. For a reader tracking the Alkem Laboratories Ltd. 52 Week Low Streak, the key point is not a single-day move alone, but the persistence of the weak pattern across consecutive sessions.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Alkem_Laboratories_Ltd_52_Week_Low_Streak_Consecutive_Low_Analysis\" title=\"Alkem Laboratories Ltd. 52 Week Low Streak: Consecutive Low Analysis\">Alkem Laboratories Ltd. 52 Week Low Streak: Consecutive Low Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#What_the_Repeated_52-Week_Lows_Show\" title=\"What the Repeated 52-Week Lows Show\">What the Repeated 52-Week Lows Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Alkem_Laboratories_Ltd_ALKEM_Fundamental_Analysis\" title=\"Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis\">Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Why_Investors_Are_Watching\" title=\"Why Investors Are Watching\">Why Investors Are Watching<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#About_the_Company\" title=\"About the Company\">About the Company<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#What_does_Alkem_Laboratories_Ltd_52_Week_Low_Streak_mean\" title=\"What does Alkem Laboratories Ltd. 52 Week Low Streak mean?\">What does Alkem Laboratories Ltd. 52 Week Low Streak mean?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Has_Alkem_Laboratories_Ltd_hit_a_new_52-week_low_today\" title=\"Has Alkem Laboratories Ltd. hit a new 52-week low today?\">Has Alkem Laboratories Ltd. hit a new 52-week low today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#What_was_Alkem_Laboratories_Ltd_trading_at_in_the_latest_update\" title=\"What was Alkem Laboratories Ltd. trading at in the latest update?\">What was Alkem Laboratories Ltd. trading at in the latest update?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Is_Alkem_Laboratories_Ltd_expensive_on_valuation\" title=\"Is Alkem Laboratories Ltd. expensive on valuation?\">Is Alkem Laboratories Ltd. expensive on valuation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#How_do_Alkem_Laboratories_Ltd_ROE_and_ROCE_compare_with_the_sector\" title=\"How do Alkem Laboratories Ltd. ROE and ROCE compare with the sector?\">How do Alkem Laboratories Ltd. ROE and ROCE compare with the sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#How_does_Alkem_Laboratories_Ltd_compare_with_pharma_peers\" title=\"How does Alkem Laboratories Ltd. compare with pharma peers?\">How does Alkem Laboratories Ltd. compare with pharma peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#What_should_investors_monitor_next_in_Alkem_Laboratories_Ltd_Stock_News\" title=\"What should investors monitor next in Alkem Laboratories Ltd. Stock News?\">What should investors monitor next in Alkem Laboratories Ltd. Stock News?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-alkem-laboratories-ltd-share-near-52-week-consecutive-low-2026\/#Track_Alkem_Laboratories_Ltd_ALKEM_Share_Price_on_Univest\" title=\"Track Alkem Laboratories Ltd. (ALKEM) Share Price on Univest\">Track Alkem Laboratories Ltd. (ALKEM) Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Alkem_Laboratories_Ltd_52_Week_Low_Streak_Consecutive_Low_Analysis\"><\/span><strong>Alkem Laboratories Ltd. 52 Week Low Streak: Consecutive Low Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,119<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,146<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -27 (-0.52%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,199.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,199.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 5,115<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 62,609.02 crore<\/td>\n<\/tr>\n<\/table>\n<p>Alkem Laboratories Ltd. (ALKEM) traded at Rs 5,119 versus the previous close of Rs 5,146, a fall of 0.52%. The stock opened at Rs 5,199.35, reached a high of Rs 5,199.35, touched a low of Rs 5,115.<\/p>\n<p>Alkem Laboratories Ltd. Share Price Today remained under pressure as the stock was last trading at Rs 5,119, down Rs 27 or 0.52% from the previous close of Rs 5,146. The intraday range so far has been narrow but firm on the downside, with the stock opening at Rs 5,199.35, touching a high of Rs 5,199.35 and slipping to a low of Rs 5,115. That places the Alkem Laboratories Ltd. Share Price Today very close to the lower end of the day\u2019s range and near the 52-week trough identified in the streak.<\/p>\n<p>The market capitalisation was Rs 62,609.02 crore, which keeps the company firmly in the large listed space even as the Alkem Laboratories Ltd. Share Price Today continues to reflect repeated weakness. The first session of this pattern started on 30 September 2026, and the second straight session confirms that the stock is still trading near its yearly low rather than staging any meaningful rebound. For investors following Alkem Laboratories Ltd. Stock News, the repeated proximity to the 52-week low is the main signal to watch, not just the small daily move.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Lows_Show\"><\/span><strong>What the Repeated 52-Week Lows Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alkem Laboratories Ltd. 52 Week Low Streak is important because it shows persistence rather than a one-off dip. The stock has stayed within 2% of its 52-week low for a second straight session, and the cumulative decline across that span is 2.24%. That means the weakness has carried over instead of fading after the first breakdown. Alkem Laboratories Ltd. New One Year Low is not being claimed here; the data only confirms that the share has been trading close to its 52-week trough across consecutive sessions.<\/p>\n<p>From a market-reading standpoint, the pattern tells readers that the Alkem Laboratories Ltd. 52 Week Low Streak is still developing. The supplied figures confirm the streak, the current trough and the move across the two sessions, but they do not identify a company-specific trigger. In practical terms, the repeated low is a factual sign of continued pressure, and the next watchpoint is whether the stock keeps trading near this band or moves away from it. That is why searches such as Alkem Laboratories Ltd. Back To Back 52 Week Lows and Stocks At One Year Low Today fit this event closely.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Alkem_Laboratories_Ltd_ALKEM_Fundamental_Analysis\"><\/span><strong>Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 62,609.02 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.52x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.29%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.28%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 180.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,196.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.03%<\/td>\n<\/tr>\n<\/table>\n<p>Alkem Laboratories Ltd. (ALKEM) fundamental metrics show P\/E 28.52x, P\/B 4.3x, ROE 18.29%, ROCE 21.28%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Alkem Laboratories Ltd. has a market capitalisation of Rs 62609.02 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 28.52x, P\/B at 4.3x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.29% and ROCE of 21.28%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 180.45, book value per share of Rs 1196.51, dividend yield of 1.03%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 27.95x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.52x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.95x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">41.83x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 688.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.84x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.29%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.28%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.46%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 62,609.02 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 765.11 crore<\/td>\n<\/tr>\n<\/table>\n<p>Alkem Laboratories Ltd. (ALKEM) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Alkem Laboratories Ltd. (ALKEM) has a P\/E ratio of 28.52x, which is above the benchmark median of 27.95x, a difference of +2.04%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Alkem Laboratories Ltd. (ALKEM) has a ROE of 18.29%, which is above the benchmark median of 11.7%, a difference of +56.32%. Alkem Laboratories Ltd. (ALKEM) has a ROCE of 21.28%, which is above the benchmark median of 13.46%, a difference of +58.1%.<\/p>\n<p>Track stocks falling to yearly lows through the <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/biocon\/biocon-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Biocon Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BIOCON<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">61,602.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">122.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.26<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/glenmark\/glenmark-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Glenmark Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GLENMARK<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">67,592.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/abbotindia\/abbott-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Abbott India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ABBOTINDIA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">57,939.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">35.73<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46.72<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Gland Pharma Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GLAND<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">49,315.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">42.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.96<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Ipca Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">IPCALAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">49,280.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">37.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.41<\/td>\n<\/tr>\n<\/table>\n<p>Alkem Laboratories Ltd. (ALKEM) has a P\/E ratio of 28.52x compared with the displayed peer median of 37.33x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.29% compares with a peer median of 14.1% across the companies shown in the table. ROCE stood at 21.28% versus the displayed peer median of 19.41%, providing a capital-efficiency comparison. Alkem Laboratories Ltd. (ALKEM) has a market capitalisation of Rs 62,609.02 crore. Among the 5 peers shown, 1 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching\"><\/span><strong>Why Investors Are Watching<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Alkem Laboratories Ltd. 52 Week Low Streak has now run for a second straight session, which keeps the share near its yearly low.<\/li>\n<li>The cumulative move across the streak is down 2.24%, making the pattern more than a one-session dip.<\/li>\n<li>The supplied data confirms the repeated-low pattern but does not establish a company-specific cause for the weakness.<\/li>\n<li>Valuation metrics and return ratios remain important because the company is still generating healthy ROE and ROCE relative to the industry.<\/li>\n<li>Peers in the healthcare and pharma space show a wide spread in valuation, so Alkem Laboratories Ltd. Share Price needs to be read in sector context.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_the_Company\"><\/span><strong>About the Company<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alkem Laboratories Ltd. operates in the Pharmaceuticals &#038; Drugs industry within the Healthcare sector. The company is tracked on NSE and BSE and remains one of the more established healthcare names by market capitalisation. In the supplied figures, the business shows a market value of Rs 62,609.02 crore, supported by earnings per share of Rs 180.45 and book value of Rs 1,196.51.<\/p>\n<p>The current numbers also show a P\/E of 28.52, P\/B of 4.3, ROE of 18.29% and ROCE of 21.28%. Those metrics matter because they help place the Alkem Laboratories Ltd. 52 Week Low Streak in a broader company context rather than treating the price move as a standalone event. The article data does not provide an ownership snapshot, so the analysis here remains centred on price, valuation and industry comparison.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Alkem_Laboratories_Ltd_52_Week_Low_Streak_mean\"><\/span><strong>What does Alkem Laboratories Ltd. 52 Week Low Streak mean?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> It means Alkem Laboratories Ltd. has traded within 2% of its 52-week low for a second straight session. The pattern shows repeated weakness near the yearly low, but it does not by itself explain why the stock is under pressure.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Has_Alkem_Laboratories_Ltd_hit_a_new_52-week_low_today\"><\/span><strong>Has Alkem Laboratories Ltd. hit a new 52-week low today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms that the stock traded near its 52-week low, with an intraday low of Rs 5,115. It does not say that a new 52-week low was definitively set today.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Alkem_Laboratories_Ltd_trading_at_in_the_latest_update\"><\/span><strong>What was Alkem Laboratories Ltd. trading at in the latest update?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> At the reported time, Alkem Laboratories Ltd. was last trading at Rs 5,119, compared with the previous close of Rs 5,146. The stock remained close to the lower end of the day\u2019s range.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Alkem_Laboratories_Ltd_expensive_on_valuation\"><\/span><strong>Is Alkem Laboratories Ltd. expensive on valuation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Its P\/E of 28.52 and P\/B of 4.3 sit near to slightly above industry medians in the supplied healthcare data. That does not make it extreme, but it also does not suggest a deep valuation discount.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_Alkem_Laboratories_Ltd_ROE_and_ROCE_compare_with_the_sector\"><\/span><strong>How do Alkem Laboratories Ltd. ROE and ROCE compare with the sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alkem Laboratories Ltd. has ROE of 18.29% and ROCE of 21.28%, both above the supplied industry medians. That indicates relatively strong return metrics even while the share price remains weak.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Alkem_Laboratories_Ltd_compare_with_pharma_peers\"><\/span><strong>How does Alkem Laboratories Ltd. compare with pharma peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Compared with peers like Lupin, Glenmark, Abbott India and Biocon, Alkem sits in the middle on valuation and profitability. Its peer comparison shows a balanced but not clearly cheap profile.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_Alkem_Laboratories_Ltd_Stock_News\"><\/span><strong>What should investors monitor next in Alkem Laboratories Ltd. Stock News?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should watch whether the share keeps trading near the 52-week low or moves away from it. The key point is the repeated pattern itself, since the supplied data confirms weakness but not a specific trigger.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Alkem_Laboratories_Ltd_ALKEM_Share_Price_on_Univest\"><\/span><strong>Track Alkem Laboratories Ltd. (ALKEM) Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/alkem\/alkem-laboratories-ltd-share-price-today\">Alkem Laboratories Ltd. (ALKEM) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-low lists and related market analysis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alkem Laboratories Ltd. Share Price trades near its 52-week low at Rs 5,119, marking a 0.52% decline today. Market cap stands at Rs 62,609.02 crore.<\/p>\n","protected":false},"author":38,"featured_media":282665,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-282666","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["282665"],"rank_math_title":["Alkem Laboratories Ltd. 52 Week Low Streak and valuation"],"rank_math_description":["Alkem Laboratories Ltd. has stayed near its 52-week low for a second straight session. Read the price action, valuation and sector context."],"rank_math_focus_keyword":["Alkem Laboratories Ltd. 52 Week Low Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/alkem-laboratories-ltd-alkem-52-week-low-streak-second-straight-session-near.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/282666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=282666"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/282666\/revisions"}],"predecessor-version":[{"id":282667,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/282666\/revisions\/282667"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/282665"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=282666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=282666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=282666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}